Pfizer generated free cash flow of $10.4 billion in the 12 months ending Sept. 30, 2025. During this period, the pharma giant ...

Set clear retirement goals, and boost your financial security with actionable investment strategies. Read what investors need ...

Enterprise Products Partners ( EPD 0.03%) pays an annual forward dividend of $2.18 per share, and a yield of approximately ...

The company has one of the world's healthiest financial profiles. Johnson & Johnson is one of only two companies in the world ...

These supercharged income stocks -- sporting an average yield of 8.51% -- can fatten investors' wallets in the new year.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Passive income investors should want to know whether a ...

The majority of its portfolio operates under long-term, triple-net leases, where the tenant is responsible for property taxes ...

High yield vs. dividend growth: learn why post-cut buys can lock double-digit yields, capture earnings recovery, and boost ...

Pfizer Inc. (NYSE:PFE) is one of the Best Dividend Leaders to Buy Now. The company’s strategy focuses on steadily increasing its dividend, reinvesting in the business with strong financial returns, ...

A cash-rich miner pays you now and builds for tomorrow. Here's why DPM could outpace the TSX in a TFSA without chasing yield.

Retirees seeking dividend income face a fundamental choice: prioritize immediate cash flow or accept lower yield for capital ...

A falling price doesn’t automatically mean “buy more,” but these three dividend payers may be worth a closer look. The post 3 Dividend Stocks to Double Up on Right Now appeared first on The Motley ...